---
annotations:
- type: Pathway Ontology
  value: protein degradation pathway
authors:
- ReactomeTeam
- Anwesha
- Eweitz
description: Matrix metalloproteinases (MMPs), previously referred to as matrixins
  because of their role in degradation of the extracellular matrix (ECM), are zinc
  and calcium dependent proteases belonging to the metzincin family. They contain
  a characteristic zinc-binding motif HEXXHXXGXXH (Stocker & Bode 1995) and a conserved
  Methionine which forms a Met-turn. Humans have 24 MMP genes giving rise to 23 MMP
  proteins, as MMP23 is encoded by two identical genes. All MMPs contain an N-terminal
  secretory signal peptide and a prodomain with a conserved PRCGXPD motif that in
  the inactive enzyme is localized with the catalytic site, the cysteine acting as
  a fourth unpaired ligand for the catalytic zinc atom. Activation involves delocalization
  of the domain containing this cysteine by a conformational change or proteolytic
  cleavage, a mechanism referred to as the cysteine-switch (Van Wart & Birkedal-Hansen
  1990).  Most MMPs are secreted but the membrane type MT-MMPs are membrane anchored
  and some MMPs may act on intracellular proteins. Various domains determine substrate
  specificity, cell localization and activation (Hadler-Olsen et al. 2011). MMPs are
  regulated by transcription, cellular location (most are not activated until secreted),
  activating proteinases that can be other MMPs, and by metalloproteinase inhibitors
  such as the tissue inhibitors of metalloproteinases (TIMPs). MMPs are best known
  for their role in the degradation and removal of ECM molecules. In addition, cleavage
  of the ECM and other cell surface molecules can release ECM-bound growth factors,
  and a number of non-ECM proteins are substrates of MMPs (Nagase et al. 2006). MMPs
  can be divided into subgroups based on domain structure and substrate specificity
  but it is clear that these are somewhat artificial, many MMPs belong to more than
  one functional group (Vise & Nagase 2003, Somerville et al. 2003).  View original
  pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=1474228 Reactome].
last-edited: 2021-05-28
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP2774
- /instance/WP2774
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP2774.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Matrix metalloproteinases (MMPs), previously referred to as matrixins
    because of their role in degradation of the extracellular matrix (ECM), are zinc
    and calcium dependent proteases belonging to the metzincin family. They contain
    a characteristic zinc-binding motif HEXXHXXGXXH (Stocker & Bode 1995) and a conserved
    Methionine which forms a Met-turn. Humans have 24 MMP genes giving rise to 23
    MMP proteins, as MMP23 is encoded by two identical genes. All MMPs contain an
    N-terminal secretory signal peptide and a prodomain with a conserved PRCGXPD motif
    that in the inactive enzyme is localized with the catalytic site, the cysteine
    acting as a fourth unpaired ligand for the catalytic zinc atom. Activation involves
    delocalization of the domain containing this cysteine by a conformational change
    or proteolytic cleavage, a mechanism referred to as the cysteine-switch (Van Wart
    & Birkedal-Hansen 1990).  Most MMPs are secreted but the membrane type MT-MMPs
    are membrane anchored and some MMPs may act on intracellular proteins. Various
    domains determine substrate specificity, cell localization and activation (Hadler-Olsen
    et al. 2011). MMPs are regulated by transcription, cellular location (most are
    not activated until secreted), activating proteinases that can be other MMPs,
    and by metalloproteinase inhibitors such as the tissue inhibitors of metalloproteinases
    (TIMPs). MMPs are best known for their role in the degradation and removal of
    ECM molecules. In addition, cleavage of the ECM and other cell surface molecules
    can release ECM-bound growth factors, and a number of non-ECM proteins are substrates
    of MMPs (Nagase et al. 2006). MMPs can be divided into subgroups based on domain
    structure and substrate specificity but it is clear that these are somewhat artificial,
    many MMPs belong to more than one functional group (Vise & Nagase 2003, Somerville
    et al. 2003).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=1474228
    Reactome].
  keywords:
  - 'CAPN7 '
  - HSPG2(?-4391)
  - polymer
  - Laminin-511 (cleaved
  - MMP1, 2, 3,
  - Cleaved fibronectin
  - OPTC(20-32)
  - DCN
  - 'LAMC2(?-1193) '
  - 'TLL2 '
  - 'CASP3(29-175) '
  - 'D4S-BCAN(361-911) '
  - ACAN(17-375)
  - alpha chain)
  - 'KS(2),C4S-ACAN(17-392) '
  - OPTC(115-332)
  - 'KS(2),C4S-ACAN(376-2415) '
  - 751-882
  - Elastin
  - 'D2,4(S)2-BCAN(23-395) '
  - 'BMP1 '
  - MMP14,TMPRSS6
  - Brevican(361-911)
  - 'Laminin gamma-2 degrading extracellular proteinases '
  - 7-12, 19)
  - 'CASP3(176-277) '
  - 'LAMB3(?-1172) '
  - 'CAPNS1 '
  - 'TMPRSS6 '
  - 'ADAMTS1 '
  - OPTC(20-114)
  - 'CTSL(292-333) '
  - 'CAPN11 '
  - 'ADAM15 '
  - 701-882
  - 'KS(2),CSE-ACAN(393-2415) '
  - Fibrillin-1
  - 'CAPN10 '
  - 'HTRA1 '
  - 'LAMA5(36-?) '
  - ELANE
  - CD44
  - 'ADAMTS8 '
  - NID1
  - 2-macroglobulin:MMP1, 3, 13, (2, 7-12, 19)
  - 9, 16, 18)
  - protein
  - 'D4S-BCAN(396-911) '
  - 'LAMA5 '
  - 'CDH1(155-700) '
  - CAST
  - 'D2,4(S)2-BCAN(396-911) '
  - 'CAPN6 '
  - MMP3, MMP7, Plasmin
  - ADAM10, ADAM15
  - Aggrecan
  - 'ADAMTS4 '
  - CAPN:4xCa2+:CAPNS
  - BSG:MMP1(100-469)
  - 'ADAMTS9 '
  - 'D2,4,4(S)3-BCAN(23-360) '
  - HTRA1 trimer
  - 'MMP8 '
  - for calpains
  - Ca2+
  - Active caspase-3
  - 'CSE-BCAN(361-911) '
  - MMP2, MMP7, MMP9
  - MMP1, MMP9, MMP12,
  - 'D2,4(S)2-BCAN(23-360) '
  - 7,8,10,13,19
  - PS1:NCSTN
  - 'LAMB3 '
  - 'PSEN1(1-298) '
  - ACAN(376-2415)
  - HSPG2(22-4391)
  - 'KS(2),CSE-ACAN(376-2415) '
  - 'MMP19 '
  - 'CAPN12 '
  - 'MMP3(100-477) '
  - 'CSE-BCAN(396-911) '
  - MMP3, CTSK, CTSL2
  - ADAMTS4, ADAMTS5
  - 'MMP14 '
  - 'ADAMTS16 '
  - MMP13, CTSS
  - 'LAMA3(?-3333) '
  - 732-882
  - 'ADAMTS18 '
  - SCUBE3(?-993)
  - 'CTSS '
  - SPP1(17-?)
  - 'C4S-BCAN(23-395) '
  - 'C4S-BCAN '
  - OPTC(20-87)
  - 'D2,4,4(S)3-BCAN(361-911) '
  - Cathepsin L1
  - 'KS(2),C6S-ACAN(17-375) '
  - 'SCUBE3 '
  - 'C4S-BCAN(23-360) '
  - CDH1(155-882):Ca2+
  - proteinases
  - substrate protein
  - Brevican(23-360)
  - 'CTSL2 '
  - Fibrillin 1,2,(3)
  - 'CAPN1 '
  - Elastin-degrading
  - OPTC(88-114)
  - polymer, SCUBE3
  - 'TLL1 '
  - 'KS(2),CSE-ACAN '
  - 'CDH1(701-882) '
  - 'KS(2),CSE-ACAN(17-375) '
  - Aggrecan(17-360)
  - 'D4S-BCAN(23-395) '
  - 'CAPN2 '
  - Laminin-332
  - calpain-cleaved
  - degrading
  - Brevican
  - MMP2, MMP9
  - 'KS(2),C6S-ACAN(17-392) '
  - 'MMP1(100-469) '
  - Aggrecan(393-2415)
  - 'CDH1(155-750) '
  - MMP10
  - MMP2(110-660)
  - 'MMP2(110-660) '
  - 'KS(2),C4S-ACAN(17-360) '
  - 'KS(2),CSE-ACAN(17-360) '
  - Brevican(23-395)
  - 'C6S-BCAN(23-360) '
  - 'KS(2),C6S-ACAN '
  - 'D4S-BCAN '
  - 'KS(2),CSE-ACAN(17-392) '
  - 'KS(2),C4S-ACAN(393-2415) '
  - MMP1, 3, 7, 12, 13,
  - 'LAMA3 '
  - NID1(29-?)
  - MMP9, KLK7
  - 'Plasmin, BMP1 '
  - CD44:MMP2, MMP7,
  - MMP3, MMP7
  - heterotetramer,
  - 'MMP10 '
  - 'KS(2),C4S-ACAN(17-375) '
  - MMP2, MMP3, MMP7
  - 'CDH1(751-882) '
  - 'MMP12 '
  - 'CAPN9 '
  - 'MMP15 '
  - SPP1(?-314)
  - ADAMTS4, 5, (1, 8,
  - HSPG2(22-?)
  - Ala(271)/Val(272)
  - NID1(?-1247)
  - A2M tetramer
  - MMP1(100-469)
  - 'D2,4,4(S)3-BCAN(23-395) '
  - 'MMP13 '
  - 'LAMB3(18-?) '
  - 'CAPN3 '
  - dimer fragment
  - 'PLG(581-810) '
  - Cleaved laminin-332
  - 'LAMC1 '
  - BMP1, TLL1, TLL2,
  - MMP2,9,12,13
  - SCUBE1,SCUBE3
  - Cleaved elastin
  - 'Cleaved fibrillin-1 '
  - Aggrecan(17-392)
  - 'MMP20 '
  - Alpha
  - 'CSE-BCAN '
  - Cleaved fibrillin-1
  - 'CAPNS2 '
  - 19, CTSS
  - 'BSG '
  - 'KS(2),C6S-ACAN(376-2415) '
  - H2O
  - Activation of Matrix
  - 'MMP11 '
  - 'Fibrillin-3 '
  - 'D2,4,4(S)3-BCAN(396-911) '
  - 'C4S-BCAN(396-911) '
  - 'LAMA3(36-?) '
  - 'C6S-BCAN '
  - 'LAMC2(22-?) '
  - 'D2,4(S)2-BCAN(361-911) '
  - extracellular
  - 'CTSK '
  - E-cadherin strand
  - 'CDH1(732-882) '
  - 'KS(2),C4S-ACAN(361-2415) '
  - Collagen degradation
  - BSG
  - Brevican(396-911)
  - 'KS(2),C6S-ACAN(393-2415) '
  - SCUBE3(21-?)
  - MMP3, plasmin,
  - 'C6S-BCAN(23-395) '
  - MMP1, 3, 13, (2,
  - 155-700
  - SCUBE3
  - Fibronectin matrix
  - DCN(?-359)
  - dimer
  - 'CAPN15 '
  - matrix
  - 'Fibrillin-2 '
  - 'ADAM10 '
  - 'A2M '
  - MMP19
  - MMP14, MMP15
  - Metalloproteinases
  - HSPG2(4197-4391)
  - calpain-1
  - 'CAPN5 '
  - 'KS(2),C4S-ACAN '
  - 'PSEN1(299-467) '
  - 'MMP9(107-707) '
  - 'CSE-BCAN(23-360) '
  - 'CAPN14 '
  - 'NCSTN '
  - OPTC(33-87)
  - 'KS(2),C6S-ACAN(17-360) '
  - 'CAPN13 '
  - DCN(31-?)
  - 1,2,(3)
  - ADAM8
  - 'C4S-BCAN(361-911) '
  - 'CDH1(155-882) '
  - 'Cleaved fibrillin-3 '
  - Aggrecan(361-2415)
  - MMP7(95-267)
  - Laminin-511
  - 'Fibrillin-1 '
  - 'LAMA5(?-3695) '
  - MMP13
  - 155-750
  - OPTC
  - 'LAMB1 '
  - 'ADAMTS5 '
  - SPP1
  - 'KS(2),CSE-ACAN(361-2415) '
  - 'Ca2+ '
  - 'PLG(20-580) '
  - 'D4S-BCAN(23-360) '
  - 'CTSL(114-288) '
  - MMP1,2,3,7,9,12,13
  - 'C6S-BCAN(361-911) '
  - 'D2,4(S)2-BCAN '
  - 'SCUBE1 '
  - 'KLK7 '
  - 'D2,4,4(S)3-BCAN '
  - 'KS(2),C6S-ACAN(361-2415) '
  - (MMP12)
  - 'CAPN8 '
  - 'CSE-BCAN(23-395) '
  - 'C6S-BCAN(396-911) '
  - 'MMP7(95-267) '
  - CTSG
  - 'ELANE '
  - 'SCUBE1,SCUBE3 polymer '
  - 'SCUBE3 polymer '
  - 'Cleaved fibrillin-2 '
  - 'CD44 '
  - Cleaved fibrillin
  - HSPG2(22-4196)
  - 'LAMC2 '
  - MMP9
  license: CC0
  name: Degradation of the extracellular matrix
seo: CreativeWork
title: Degradation of the extracellular matrix
wpid: WP2774
---